National Institute of General Medical Sciences; Notice of Meeting, 73791 [2021-28096]
Download as PDF
Federal Register / Vol. 86, No. 246 / Tuesday, December 28, 2021 / Notices
Dated: December 21, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28150 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.859, Biomedical Research and
Research Training, National Institutes of
Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–28096 Filed 12–27–21; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute of General Medical
Sciences; Notice of Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
www.nigms.nih.gov/about-nigms/whatwe-do/advisory-council).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: September 15, 2022.
Open: 9:30 a.m. to 1:30 p.m.
Agenda: For the discussion of program
policies and issues; opening remarks; report
of the Director, NIGMS; and other business
of the Council.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Closed: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Erica L. Brown, Ph.D.,
Director, Division of Extramural Activities,
National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24F, Bethesda,
MD 20892, 301–594–4499, erica.brown@
nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council, where an
agenda and any additional information for
the meeting will be posted when available.
VerDate Sep<11>2014
22:45 Dec 27, 2021
Jkt 256001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: September 7–8, 2022.
Open: September 07, 2022, 10:00 a.m. to
1:30 p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Closed: September 08, 2022, 1:30 p.m. to
2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
73791
Contact Person: Karl F. Malik, Ph.D.,
Director Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Diabetes, Endocrinology and
Metabolic Diseases Subcommittee.
Date: September 7–8, 2022.
Open: September 08, 2022, 10:00 a.m. to
11:30 a.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Closed: September 08, 2022, 11:45 a.m. to
1:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director
Division of Extramural Activities, National
Institutes of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy Boulevard,
Room 7329, MSC 5452, Bethesda, MD 20892,
(301) 594–4757, malikk@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Digestive Diseases and Nutrition
Subcommittee.
Date: September 7–8, 2022.
Open: September 08, 2022, 10:00 a.m. to
11:30 a.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Closed: September 08, 2022, 11:45 a.m. to
1:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Rooms C, D&E, and
F&G, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757 malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Kidney, Urologic and Hematologic
Diseases Subcommittee.
Date: September 7–8, 2022.
Open: September 08, 2022, 10:00 a.m. to
12:00 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Closed: September 08, 2022, 12:15 p.m. to
1:15 p.m.
E:\FR\FM\28DEN1.SGM
28DEN1
Agencies
[Federal Register Volume 86, Number 246 (Tuesday, December 28, 2021)]
[Notices]
[Page 73791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28096]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the public as indicated below, with a
short public comment period at the end. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://www.nigms.nih.gov/about-nigms/what-we-do/advisory-council).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory General Medical Sciences
Council.
Date: September 15, 2022.
Open: 9:30 a.m. to 1:30 p.m.
Agenda: For the discussion of program policies and issues;
opening remarks; report of the Director, NIGMS; and other business
of the Council.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Closed: 1:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Erica L. Brown, Ph.D., Director, Division of
Extramural Activities, National Institute of General Medical
Sciences, National Institutes of Health, Natcher Building, Room
2AN24F, Bethesda, MD 20892, 301-594-4499, [email protected].
Information is also available on the Institute's/Center's home
page: https://www.nigms.nih.gov/About/Council, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.859,
Biomedical Research and Research Training, National Institutes of
Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28096 Filed 12-27-21; 8:45 am]
BILLING CODE 4140-01-P